Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin
about
Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer ApplicationsTobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates.Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.Highlights from the 2015 North American Cystic Fibrosis Conference.Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients.
P2860
Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of Pseudomonas aeru ...... n nebulized liposomal amikacin
@en
type
label
Management of Pseudomonas aeru ...... n nebulized liposomal amikacin
@en
prefLabel
Management of Pseudomonas aeru ...... n nebulized liposomal amikacin
@en
P2860
P921
P356
P1433
P1476
Management of Pseudomonas aeru ...... n nebulized liposomal amikacin
@en
P2093
John P Clancy
Zarmina Ehsan
P2860
P304
P356
10.2217/FMB.15.117
P577
2015-11-17T00:00:00Z